市場調查報告書
商品編碼
1548167
全球輔助生殖技術市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測Global Assisted Reproductive Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球輔助生殖技術市場需求預計將從2023年的330.5億美元達到近587億美元的市場規模,2024-2032年研究期間複合年成長率為6.59%。
輔助生殖技術 (ART) 是指一系列用於解決不孕症和幫助個人懷孕的醫療程序。 ART 包括體外受精 (IVF)、胞漿內單一精子注射 (ICSI) 以及配子或胚胎冷凍保存等技術。這些方法涉及在體外操縱卵子、精子和胚胎,以提高懷孕的機會。 ART 用於傳統受孕方法因精子數量低、輸卵管阻塞或與年齡相關的生育問題等因素而失敗的情況。 ART 領域取得了重大進展,提高了成功率,並為患有不孕症的個人和夫妻提供了新的選擇。
生活方式的改變、生育延遲和生殖疾病盛行率上升導致不孕率上升,推動了輔助生殖技術市場的發展。例如,美國生殖醫學會強調,全球約有 10-15% 的夫婦患有不孕症。技術進步,例如體外受精技術的改進和基因篩檢工具的開發,為提高成功率和個人化治療提供了新的機會。此外,不同族群對 ART 治療的認知和接受程度不斷提高,也導致需求不斷成長。旨在支持不孕症治療和研究的政府措施和資金進一步促進輔助生殖技術市場的成長。這些促進因素和機會共同增強了市場發展和創新的潛力。然而,高昂的治療成本和倫理問題可能會限制輔助生殖技術市場的成長。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球輔助生殖技術市場的各個細分市場進行了包容性評估。輔助生殖技術產業的成長和趨勢為本研究提供了整體方法。
輔助生殖技術市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲輔助生殖技術市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。輔助生殖技術市場的主要參與者包括 Cosmos Biomedical、Microm UK Ltd.、Origio (CooperSurgical)、Irvine Scientific、Cryolab Ltd.、Parallabs、歐洲精子庫、Bloom IVF 中心。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Assisted Reproductive Technology Market is presumed to reach the market size of nearly USD 58.7 Billion by 2032 from USD 33.05 Billion in 2023 with a CAGR of 6.59% under the study period 2024-2032.
Assisted reproductive technology (ART) refers to a range of medical procedures used to address infertility and assist individuals in conceiving a child. ART encompasses techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete or embryo cryopreservation. These methods involve manipulating eggs, sperm, and embryos outside the body to enhance the chances of pregnancy. ART is employed in cases where traditional conception methods are unsuccessful due to factors like low sperm count, blocked fallopian tubes, or age-related fertility issues. The field of ART has seen significant advancements, improving success rates and providing new options for individuals and couples struggling with infertility.
The assisted reproductive technology market is driven by increasing infertility rates, attributed to lifestyle changes, delayed childbearing, and rising prevalence of reproductive disorders. For instance, the American Society for Reproductive Medicine highlights that infertility affects approximately 10-15% of couples globally. Technological advancements, such as improved IVF techniques and the development of genetic screening tools, offer new opportunities for enhancing success rates and personalizing treatment. Moreover, rising awareness and acceptance of ART treatments across diverse populations contribute to growing demand. Government initiatives and funding aimed at supporting infertility treatments and research further bolster assisted reproductive technology market growth. These drivers and opportunities collectively enhance the potential for market development and innovation. However, high treatment costs and ethical concerns may restrain assisted reproductive technology market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Assisted Reproductive Technology. The growth and trends of Assisted Reproductive Technology industry provide a holistic approach to this study.
This section of the Assisted Reproductive Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Assisted Reproductive Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Assisted Reproductive Technology market include Cosmos Biomedical, Microm U.K. Ltd., Origio (CooperSurgical), Irvine Scientific, Cryolab Ltd., Parallabs, European Sperm Bank, Bloom IVF Centre. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.